Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision indicator was updated from v3.6.2 to v3.6.3. This reflects an underlying site update but does not alter the study details or the information presented to users.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. No user-facing content changes are indicated.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page now states recruitment has ended and introduces new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with the Intervention/Treatment heading and a revised revision tag (Revision: v3.6.0).SummaryDifference0.6%

- Check37 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This indicates a small platform update with no change to the study information shown.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, signaling a new release of the site interface. This appears to be a maintenance update with no changes to the trial information presented on the page.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s revision indicator was updated from **v3.5.2** to **v3.5.3**. This reflects an underlying site/version change rather than a change to the trial’s content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.